Equity research analysts and market strategists tracking global equities for 2026 frequently point toward select out-of-favor corporations in the financial, energy, healthcare, and legacy technology sectors. Companies experiencing temporary cyclical pullbacks—such as major pharmaceutical firms, traditional automotive enterprises navigating energy transitions, or established semiconductor manufacturers undergoing capital expenditure phases—are often evaluated as potential value buys. Investors must balance low valuation multiples against structural industry risks before executing trades.